Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 65.30% is 22% above its 5-year average of 53.67%, near the high end of its 5-year range (38.73%–67.14%).
0.52% above its 12-month average of 64.96%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 64.46%.
GROSS MARGIN
65.30%
GROSS MARGIN AVG TTM
64.96%
GROSS MARGIN AVG 3Y
60.41%
GROSS MARGIN AVG 5Y
53.67%
GROSS MARGIN AVG 10Y
46.77%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.52%
CURRENT VS 3Y AVG
+8.09%
CURRENT VS 5Y AVG
+21.66%
CURRENT VS 10Y AVG
+39.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
59.92%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+8.97%
vs the sector median at left
Market Cap
$63.32B
Gross Margin
71.16%
TTM Avg
65.16%
3Y Avg
63.29%
5Y Avg
62.03%
Market Cap
$49.03B
Gross Margin
77.98%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
Market Cap
$48.72B
Gross Margin
46.12%
TTM Avg
45.33%
3Y Avg
44.44%
5Y Avg
44.19%
Market Cap
$47.38B
Gross Margin
53.73%
TTM Avg
53.36%
3Y Avg
52.95%
5Y Avg
53.14%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Natera, Inc. (NTRA) | $58.77B | 65.30% | 64.96% | 60.41% | 53.67% |
| Cencora, Inc. (COR)vs › | $60.13B | 3.71% | 3.06% | 3.07% | 2.95% |
| Boston Scientific Corporation (BSX)vs › | $63.32B | 71.16% | 65.16% | 63.29% | 62.03% |
| Cardinal Health, Inc. (CAH)vs › | $53.47B | 3.84% | 3.75% | 3.54% | 3.65% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 77.98% | 78.79% | 78.80% | 77.78% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 46.12% | 45.33% | 44.44% | 44.19% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 53.73% | 53.36% | 52.95% | 53.14% |
| Humana Inc. (HUM)vs › | $46.63B | 13.65% | 14.54% | 16.14% | 17.03% |
| Cigna Corporation (CI)vs › | $71.48B | 11.66% | 9.98% | 11.47% | 12.36% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 52.47% | 50.27% | 48.88% | 48.29% |
Gross Margin
65.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 64.46% |
| 2026-03-31 | 64.80% |
| 2025-12-31 | 67.14% |
| 2025-09-30 | 64.91% |
| 2025-06-30 | 63.50% |
| 2025-03-31 | 63.21% |
| 2024-12-31 | 62.94% |
| 2024-09-30 | 61.79% |
| 2024-06-30 | 58.83% |
| 2024-03-31 | 56.72% |
| 2023-12-31 | 51.38% |
| 2023-09-30 | 45.10% |
| 2023-06-30 | 45.24% |
| 2023-03-31 | 38.73% |
| 2022-12-31 | 41.41% |
| 2022-09-30 | 44.69% |
| 2022-06-30 | 44.89% |
| 2022-03-31 | 46.83% |
| 2021-12-31 | 45.60% |
| 2021-09-30 | 48.54% |
| 2021-06-30 | 46.41% |
| 2021-03-31 | 56.14% |
| 2020-12-31 | 46.71% |
| 2020-09-30 | 47.20% |
| 2020-06-30 | 45.72% |
| 2020-03-31 | 52.16% |
| 2019-12-31 | 46.59% |
| 2019-09-30 | 43.68% |
| 2019-06-30 | 41.06% |
| 2019-03-31 | 35.20% |
| 2018-12-31 | 36.10% |
| 2018-09-30 | 36.15% |
| 2018-06-30 | 35.00% |
| 2018-03-31 | 34.89% |
| 2017-12-31 | 31.69% |
| 2017-09-30 | 38.91% |
| 2017-06-30 | 35.54% |
| 2017-03-31 | 28.15% |
| 2016-12-31 | 22.92% |
| 2016-09-30 | 36.42% |
| 2016-06-30 | 40.42% |
| 2016-03-31 | 47.76% |
| 2015-12-31 | 39.87% |
| 2015-09-30 | 32.20% |
| 2015-06-30 | 42.93% |
| 2015-03-31 | 47.63% |
| 2014-12-31 | 54.57% |
| 2014-09-30 | 55.01% |
| 2014-06-30 | 46.94% |
| 2014-03-31 | 41.75% |
| 2013-12-31 | 45.10% |
| 2013-09-30 | 41.27% |
| 2013-03-31 | -30.14% |
